ArticleBiomimetics (Basel, Switzerland)2025
Novel Clinical Applications of 3D-Printed Highly Porous Titanium for Off-the-Shelf Cementless Joint Replacement Prostheses.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Chemical Post-Processing of SLM Ti6Al4V Structures Using HF with Propylene Glycol: Surface, Structural and Biological Evaluation of an Exploratory Post-Processing Strategy.Materials (Basel, Switzerland) · 2026Article
- Review
- Review
- Three dimensional printing in unicompartmental knee arthroplasty: current evidence and future directions.International orthopaedics · 2026Review
- Multiscale Interface Engineering for Orthopedic and Dental Implants: A Review.Journal of functional biomaterials · 2026Review
- 3D Skeletal Scaffolds of Marine Keratosan Demosponges Origin as Renewable Sources for Bioinspiration in Modern Structural Biomimetics and Tissue Engineering.Biomimetics (Basel, Switzerland) · 2026Review
- A narrative review of clinical research on knee osteoarthritis in 2025.Annals of joint · 2026Review
- Reframing Fixation Strategy in Total Knee Arthroplasty With Tibial Bone Density as a Central Criterion.JB & JS open accessReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In total joint replacement, early aseptic loosening of implants caused by inadequate initial fixation and late aseptic loosening due to stress shielding-related periprosthetic bone remodeling are the main causes of failure. Over the last two decades, additive manufacturing has been revolutionizing the design of cementless orthopaedic implants by enabling biomimetic, highly porous titanium structures that enhance bone ingrowth and osseointegration while reducing stress shielding. The synergy between optimized selective laser-melted highly porous titanium bearing components, ceramic-coated titanium articular surfaces, and vitamin E-stabilized polyethylene liners delivers several benefits essential for implant longevity: reliable initial fixation, improved biological fixation, reduced bone resorption caused by stress shielding, and lower osteolytic reactivity. These benefits have encouraged the synergetic use of these technologies in joint replacement in novel clinical applications. In recent years, novel off-the-shelf, 3D-printed, highly porous titanium implants have been introduced into hip and knee arthroplasty. These newly introduced implants appear to offer an innovative and promising solution, and are particularly indicated for young active patients, elderly patients with osteoporotic bones, and in complex cases. Future clinical research should confirm these novel implants' superior results in comparison to the current state of the art in cementless joint replacement. The possibility of extending these technologies in the future to other clinical applications such as partial knee prosthesis is discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.